LC IIsp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2011-01-10
Share capital
5,000.00 PLN
Registered address
ul. Franciszka Barcza 58/U18, 10-685 Olsztyn, Poland
Electronic delivery address
AE:PL-88837-53512-SHRTI-25
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $41 |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 335 days for 2021).
- 202529/06/2026
- 202411/08/2025
- 202322/08/2024
- 202217/12/2023
- 202115/06/2023
- 202014/01/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Other research and experimental development on natural sciences and engineering682 / 1,565
Top 44%
Results vs industry
Revenue
This companyUSD 112.75kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 17.00kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 94.87kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 16.12kMedianUSD 119.88kAverageUSD 3.90m
Industry
Public procurement
No recorded participation in tenders.
LC II is the contractor in 2 public sector contracts, worth USD 1.80k in total. All of them were signed with the same public buyer.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 16, 2026 | Inspection of an otolaryngological operating microscope | $1,351 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | |
| Oct 1, 2026 | Microscope repair | $445.71 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego |
Authorized Representatives
Jakub Paweł Szczerbukage 43 – President of the Management Board
Manner of representation
One-person representation.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jakub Paweł Szczerbukage 43 | 96 | $1,296.60 | 96% |
Others | 4 | $54.02 | 4% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-09-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 11, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jul 3, 2019 | Regional investment aid | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Rybactwa Śródlądowego Im. Stanisława Sakowicza - Państwowy Instytut BadawczyResearch institute | $14,366,048.38 | infish.com.pl | ||
| Etyka Ośrodek Badań Klinicznych Tomasz PestaS.K.A. | $514,414.85 | etykaosrodek.pl | ||
| Recometalsp. z o.o. | $114,425.74 | recometal.pl | ||
| Bacteromicsp. z o.o. | $112,732.71 | bacteromic.com | ||
| ConnectomeP.S.A. | $107,988.50 | connectome.name | ||
| Uhura Bionicssp. z o.o. | $88,274.48 | uhura.pl | ||
| ATER Netsp. z o.o. | $58,127.56 | aternet.pl | ||
| Akademia Integracji Medycznejsp. z o.o. | $13.42 | aim-medica.pl | ||
| Kimika Laboratoriessp. z o.o. | $0.00 | kimika.pl | ||
| Upthermo Orcsp. z o.o. | $0.00 | upthermo.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-20 | Name change (Labo Clinic Ii → Lc Ii) | |
| 2023-06-23 | Name change (Labo Clinic → Labo Clinic Ii) | |
| 2021-10-12 | PKD change (Added: 72.19.Z) | |
| 2020-05-07 | Address change (Dworcowa 41 A/2, 10-437, Olsztyn → Ul. Franciszka Barcza 58/U18, 10-685, Olsztyn) | |
| 2011-01-10 | Entered in the register |
FAQ
The main business activity of LC II focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on January 10, 2011.
The headquarters is located at: ul. Franciszka Barcza 58, 10-685 Olsztyn.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 112,747 in 2025, which is a decrease of 19.5% compared to 2024.
Yes, in 2025 the company achieved a net profit of USD 16,998.
The largest operating cost category falls under other operating costs. This category amounted to USD 79,830 in 2025, representing 84% of all operating expenses.
Last updated: 2026-08-20
